Royal Bank of Canada
ABVX

Royal Bank of Canada’s Abivax ABVX Stock Holding History

Royal Bank of Canada’s Portfolio ABVX Stock Details ABVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.68M Sell
15,123
-15,744
-51% -$1.86M ﹤0.01% 3224
2025
Q4 		$4.16M Buy
30,867
+27,912
+945% +$3.05M ﹤0.01% 2569
2025
Q3 		$251K Buy
+2,955
New +$181K ﹤0.01% 4937
2025
Q1 		– Sell
-37
Closed – – 6759
2024
Q4 		$0 Buy
+37
New +$341 ﹤0.01% 6853

Other funds holding ABVX

TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.77B AUM 307.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
CP
Caligan Partners New York $1.5B AUM 518.95% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
HI
Helikon Investments London, United Kingdom $2.65B AUM 79.03% 1-Year Est. Return

Royal Bank of Canada's ABVX Position: Q1 2026 in Review

Royal Bank of Canada reduced its Abivax (ABVX) stake by 51% in Q1 2026, selling an estimated $1.86M and leaving 15,123 shares worth $1.68M. The position accounts for ﹤0.01% of the portfolio, ranked #3224.

Royal Bank of Canada first reported a position in ABVX in Q4 2024 and has held it in 4 quarters since. The position peaked at $4.16M in Q4 2025. 254 funds tracked by Wall St. Rank hold ABVX as of Q1 2026.

  • Royal Bank of Canada held 15,123 shares of Abivax worth $1.68M as of Q1 2026.
  • Royal Bank of Canada sold 15,744 Abivax shares in Q1 2026, an estimated $1.86M.
  • Abivax made up ﹤0.01% of Royal Bank of Canada's portfolio in Q1 2026, its #3224 holding.
  • Royal Bank of Canada first reported a position in Abivax in Q4 2024 and has held it in 4 quarters since.
  • Royal Bank of Canada's Abivax position peaked at $4.16M in Q4 2025.
  • 254 funds tracked by Wall St. Rank held Abivax as of Q1 2026.

Based on Royal Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.